Antimalarial drug persists in mosquitoes for days, potentially exposing developing parasites

· Medical Xpress

by Janice Hur, Yale University

edited by Sadie Harley, reviewed by Robert Egan

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source


DEAQ is absorbed dose dependently and detectable beyond midgut epithelium up to 5 days following bloodmeal ingestion. A, Cartoon of mosquito anatomy upon bloodmeal ingestion. B, Laboratory mosquitoes were fed bloodmeals containing 40% hematocrit red blood cells and 1 µg/mL or 250 ng/mL DEAQ to represent twice (2×) and half (1/2×) reported Cmax, respectively. Credit: The Journal of Infectious Diseases (2026). DOI: 10.1093/infdis/jiag300

Antimalarial drugs are designed to protect people from malaria, but they may also affect the mosquitoes exposed to them during blood meals. A new Yale study, published in The Journal of Infectious Diseases, investigates the impact of these medications on mosquitoes, laying the groundwork for future research into how the drugs may influence the malaria parasites developing within them.

"I was really interested in trying to understand more about drug resistance transmission dynamics in sub-Saharan Africa," says Morgan Goheen, M.D., Ph.D., instructor (infectious diseases) at Yale School of Medicine and first author of the study. "The more we thought about it, the more it was obvious that mosquitoes must be ingesting these drugs when they feed on people who have taken them."

Blood meals may expose developing parasites

Malaria parasites require both humans and mosquitoes to complete their life cycle. After a mosquito feeds on an infected person, the parasites spend about 10–14 days developing inside the mosquito before they can be transmitted to another person. During that time, mosquitoes continue taking blood meals from other people. Because antimalarial drug use is widespread in malaria-endemic regions, some of those blood meals are likely to come from people taking the medications.

"We thought there was a high likelihood that infected mosquitoes are ingesting antimalarials during the time period that parasites are developing within them," Goheen says. "So we wondered, what effect do drugs have on parasites within the mosquitoes?"

A drug moves beyond the mosquito's gut

Before answering that question, the researchers first needed to establish two things: whether commonly used long-acting antimalarial drugs affected mosquitoes and whether the drugs could move beyond the mosquito's gut after a blood meal.

The team found that the drugs did not affect mosquito survival, feeding behavior or reproduction. More notably, the findings showed that desethylamodiaquine—the active form of one of the world's most widely used antimalarial drugs—was absorbed into the mosquito's circulatory fluid and remained detectable for several days.

"To our knowledge, it's the first time that someone has demonstrated that in mosquitoes ingesting long-acting antimalarials via blood meal, the drugs can be absorbed into their circulatory fluid and be present for long periods," Goheen says. "That means that parasites developing in the mosquito are certainly being exposed to these drugs."

"It's not like the drugs are kept in their gut and then excreted by the mosquito," she adds.

Investigating effects on development and drug resistance

Working at Yale and in Burkina Faso, West Africa, Goheen and her team are currently investigating whether that exposure affects parasite development or contributes to drug resistance.

Although the research is still in its early stages, Goheen hopes it encourages scientists to view malaria transmission more holistically.

"The antimalarial prevention measures that we use may have other impacts on the parasite that we haven't been thinking about," she says. "Gaining a better understanding of how drugs interact with parasites inside mosquitoes could inform future efforts to slow the spread of drug-resistant malaria and help identify new ways to interrupt transmission."

Publication details

Morgan M Goheen et al, Anopheles Mosquitoes Exposed to Long-Acting Antimalarials via Drug-Supplemented Bloodmeal Absorb Drug but Do Not Suffer Fitness Costs, The Journal of Infectious Diseases (2026). DOI: 10.1093/infdis/jiag300

Journal information: Journal of Infectious Diseases

Key medical concepts

Culicidae

Clinical categories

Infectious diseasesClinical pharmacology Provided by Yale University Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Antimalarial drug persists in mosquitoes for days, potentially exposing developing parasites (2026, October 6) retrieved 6 October 2026 from https://medicalxpress.com/news/2026-10-antimalarial-drug-persists-mosquitoes-days.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.